Search
Lantern Pharma Inc
LTRNAdd to Watchlist
1.390USD
+0.030+2.21%
Close 09-22 16:00（ET）
17.74MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+2.21%
5 Days
-18.24%
1 Month
-40.60%
6 Months
-34.74%
Year to Date
-54.13%
1 Year
-66.59%
Key Figures
1.350Open
1.640High
12.49KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
1.360Prev. Close
1.345Low
17.60KTurnover
LossP/E Static
-5.47P/B
0.00%Div Yield TTM
-112.37%ROA
4.70352wk High
0.03Volume Ratio
-20.78MNet Profit
12.76MShares
-1.4460EPS TTM
2.27Beta
-157.37%ROE
1.11052wk Low
21.69%Amplitude
--Gross Margin
17.74MMarket Cap
-1.69Reward/Risk
6.21%Risk Rate
Analyst Rating
Lantern Pharma Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Lantern Pharma Inc Latest Earnings Call Transcripts
Lantern Pharma (LTRN) Q2 2026 Earnings Call: Lower Operating Loss, LP-300 and Open Medicine AI
Lantern Pharma Q2 2026 earnings call: operating loss fell 25% to $3.5M, cash was $7.4M, while LP-300 and Open Medicine AI advanced.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.57/-0.38
Revenue / Forecast
--/0.00
Lantern Pharma Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolLTRN
Number of employees24
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Biological Mimetics, Inc | 7.47% |
| Bios Equity Partners, LP. | 7.38% |
| Prophase Labs Inc | 5.58% |
| Satterfield (Thomas A Jr) | 5.04% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 13.05% |
| Investment Advisor | 7.58% |
| Venture Capital | 7.38% |
| Individual Investor | 5.45% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%
FAQs
What is the current price of Lantern Pharma Inc (LTRN)?
The current price of Lantern Pharma Inc (LTRN) is 1.36.
What is the symbol of Lantern Pharma Inc?
The ticker symbol of Lantern Pharma Inc is LTRN.
What is the 52-week high of Lantern Pharma Inc?
The 52-week high of Lantern Pharma Inc is 4.70.
What is the 52-week low of Lantern Pharma Inc?
The 52-week low of Lantern Pharma Inc is 1.11.
What is the market capitalization of Lantern Pharma Inc?
The market capitalization of Lantern Pharma Inc is 17.35M.
Is Lantern Pharma Inc (LTRN) currently rated as Buy, Hold, or Sell?
According to analysts, Lantern Pharma Inc (LTRN) has an overall rating of Buy, with a price target of 17.50.
What is the Earnings Per Share (EPS TTM) of Lantern Pharma Inc (LTRN)?
The Earnings Per Share (EPS TTM) of Lantern Pharma Inc (LTRN) is -1.45.